Adipose Tissue Dysfunction as Determinant of Obesity-Associated Metabolic Complications
Дисфункция жировой ткани как детерминанта метаболических осложнений, связанных с ожирением
2019-05-13
SCID: 54.1/x7hvmsyg
Discuss with AI
adipose tissue dysfunctionchronic low-grade inflammationectopic lipid accumulationinsulin resistanceobesity-associated metabolic complications
Figures from the paper
Abstract (AI)
Obesity is a critical risk factor for the development of type 2 diabetes (T2D), and its prevalence is rising worldwide. White adipose tissue (WAT) has a crucial role in regulating systemic energy homeostasis. Adipose tissue expands by a combination of an increase in adipocyte size (hypertrophy) and number (hyperplasia). The recruitment and differentiation of adipose precursor cells in the subcutaneous adipose tissue (SAT), rather than merely inflating the cells, would be protective from the obesity-associated metabolic complications. In metabolically unhealthy obesity, the storage capacity of SAT, the largest WAT depot, is limited, and further caloric overload leads to the fat accumulation in ectopic tissues (e.g., liver, skeletal muscle, and heart) and in the visceral adipose depots, an event commonly defined as "lipotoxicity." Excessive ectopic lipid accumulation leads to local inflammation and insulin resistance (IR). Indeed, overnutrition triggers uncontrolled inflammatory responses in WAT, leading to chronic low-grade inflammation, therefore fostering the progression of IR. This review summarizes the current knowledge on WAT dysfunction in obesity and its associated metabolic abnormalities, such as IR. A better understanding of the mechanisms regulating adipose tissue expansion in obesity is required for the development of future therapeutic approaches in obesity-associated metabolic complications.
Key Findings
1
Ectopic lipid accumulation induces local inflammation and insulin resistance in tissues such as the liver, skeletal muscle, and heart.
2
Limited storage capacity in subcutaneous adipose tissue promotes lipid deposition in visceral depots and ectopic tissues, causing lipotoxicity.
3
Overnutrition triggers chronic low-grade inflammation in white adipose tissue, contributing to the progression of systemic insulin resistance.
4
Subcutaneous adipose tissue expansion through precursor-cell recruitment and differentiation may protect against obesity-associated metabolic complications.
5
Understanding mechanisms regulating adipose tissue expansion is necessary for developing therapies targeting obesity-associated metabolic complications.
Research Object
White adipose tissue (WAT) dysfunction in obesity, particularly involving subcutaneous adipose tissue expansion and ectopic lipid accumulation
Research Subject
The mechanisms by which impaired adipose tissue expansion, lipotoxicity, inflammation, and insulin resistance contribute to obesity-associated metabolic complications
Publication Details
Publication Date
2019-05-13
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest